Which threshold for ER positivity? a retrospective study based on 9639 patients
Yi, M., Huo, L., Koenig, K.B., Mittendorf, E.A., Meric-Bernstam, F., Kuerer, H.M., Bedrosian, I., Buzdar, A.U., Symmans, W.F., Crow, J.R., Bender, M., Shah, R.R., Hortobagyi, G.N., Hunt, K.K.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial
Buzdar, A, Howell, A, Cuzick, J, Wale, C, Distler, W, Hoctin-Boes, G, Houghton, J, Locker, G Y, Nabholtz, J M
Published in The lancet oncology (01.08.2006)
Published in The lancet oncology (01.08.2006)
Get full text
Journal Article
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Kaufmann, M., von Minckwitz, G., Bear, H.D., Buzdar, A., McGale, P., Bonnefoi, H., Colleoni, M., Denkert, C., Eiermann, W., Jackesz, R., Makris, A., Miller, W., Pierga, J.-Y., Semiglazov, V., Schneeweiss, A., Souchon, R., Stearns, V., Untch, M., Loibl, S.
Published in Annals of oncology (01.12.2007)
Published in Annals of oncology (01.12.2007)
Get full text
Journal Article
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
Baum, M, Budzar, A U, Cuzick, J, Forbes, J, Houghton, J H, Klijn, J G M, Sahmoud, T
Published in The Lancet (British edition) (22.06.2002)
Published in The Lancet (British edition) (22.06.2002)
Get full text
Journal Article
Anastrozole Alone or in combination with Tamoxifen versus Tamoxifen Alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen Alone or in combination) trial efficacy and safety update analyses
Baum, M, Buzdar, A, Cuzick, J, Forbes, J, Houghton, J, Howell, A, Sahmoud, T
Published in Cancer (01.11.2003)
Published in Cancer (01.11.2003)
Get full text
Journal Article
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
Kim, M.M., Allen, P., Gonzalez-Angulo, A.M., Woodward, W.A., Meric-Bernstam, F., Buzdar, A.U., Hunt, K.K., Kuerer, H.M., Litton, J.K., Hortobagyi, G.N., Buchholz, T.A., Mittendorf, E.A.
Published in Annals of oncology (01.08.2013)
Published in Annals of oncology (01.08.2013)
Get full text
Journal Article
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial
Lesurf, R., Griffith, O.L., Griffith, M., Hundal, J., Trani, L., Watson, M.A., Aft, R., Ellis, M.J., Ota, D., Suman, V.J., Meric-Bernstam, F., Leitch, A.M., Boughey, J.C., Unzeitig, G., Buzdar, A.U., Hunt, K.K., Mardis, E.R.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
NABHOLTZ, J. M, BUZDAR, A, POLLAK, M, HARWIN, W, BURTON, G, MANGALIK, A, STEINBERG, M, WEBSTER, A, VON EULER, M
Published in Journal of clinical oncology (15.11.2000)
Published in Journal of clinical oncology (15.11.2000)
Get full text
Journal Article
Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial
OSBORNE, C. K, PIPPEN, J, WEBSTER, A, MORRIS, C, ELLEDGE, R, BUZDAR, A, JONES, S. E, PARKER, L. M, ELLIS, M, COME, S, GERTLER, S. Z, MAY, J. T, BURTON, G, DIMERY, I
Published in Journal of clinical oncology (15.08.2002)
Published in Journal of clinical oncology (15.08.2002)
Get full text
Journal Article
Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate
BUZDAR, A, DOUMA, J, DAVIDSON, N, ELLEDGE, R, MORGAN, M, SMITH, R, PORTER, L, NABHOLTZ, J, XIANG, X, BRADY, C
Published in Journal of clinical oncology (15.07.2001)
Published in Journal of clinical oncology (15.07.2001)
Get full text
Journal Article
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
Freedman, Rachel A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J., Muss, H. B.
Published in Breast cancer research and treatment (01.01.2017)
Published in Breast cancer research and treatment (01.01.2017)
Get full text
Journal Article
The sequential use of endocrine treatment for advanced breast cancer: where are we?
Barrios, C., Forbes, J.F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J.F.R.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
KUERER, H. M, NEWMAN, L. A, BUCHHOLZ, T. A, ROSS, M. I, MCNEESE, M. D, BUZDAR, A. U, HORTOBAGYI, G. N, SINGLETARY, S. E, SMITH, T. L, AMES, F. C, HUNT, K. K, DHINGRA, K, THERIAULT, R. L, SINGH, G, BINKLEY, S. M, SNEIGE, N
Published in Journal of clinical oncology (01.02.1999)
Published in Journal of clinical oncology (01.02.1999)
Get full text
Journal Article
Conference Proceeding
Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results
Nabholtz, J.M, Bonneterre, J, Buzdar, A, Robertson, J.F.R, Thürlimann, B
Published in European journal of cancer (1990) (01.08.2003)
Published in European journal of cancer (1990) (01.08.2003)
Get full text
Journal Article
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
BLUM, J. L, JONES, S. E, BUZDAR, A. U, LORUSSO, P. M, KUTER, I, VOGEL, C, OSTERWALDER, B, BURGER, H.-U, BROWN, C. S, GRIFFIN, T
Published in Journal of clinical oncology (01.02.1999)
Published in Journal of clinical oncology (01.02.1999)
Get full text
Journal Article
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
Mazouni, C, Kau, S-W, Frye, D, Andre, F, Kuerer, HM, Buchholz, TA, Symmans, WF, Anderson, K, Hess, KR, Gonzalez-Angulo, AM, Hortobagyi, GN, Buzdar, AU, Pusztai, L
Published in Annals of oncology (01.05.2007)
Published in Annals of oncology (01.05.2007)
Get full text
Journal Article
Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers
MAZOUNI, C, ARUN, B, ANDRE, F, AYERS, M, KRISHNAMURTHY, S, WANG, B, HORTOBAGYI, G. N, BUZDAR, A. U, PUSZTAI, L
Published in British journal of cancer (08.07.2008)
Published in British journal of cancer (08.07.2008)
Get full text
Journal Article